IPO Pipeline Surges as Jar Faces Legal Heat: A Mixed Signal Day for Indian Startups

Atomberg getting board approval for a ₹450 Cr IPO is the headline here. For a D2C appliance brand that started with B2B fans in 2012, this is the home stretch. The market's appetite is further validated by Molbio Diagnostics' 21% listing premium on Monday and the Shiprocket IPO allotment finalized today. On the balance sheet front, API Holdings (PharmEasy parent) has wiped out ₹1,050 Cr in debt, turning debt-free. This trio of events—IPOs, strong...